Biography
I holds a PhD in Pharmacy and has been affiliated with the Korean Institute of Tuberculosis since 2008. My research primarily focuses on the development of bacteriophages as therapeutic agents for tuberculosis (TB) and non-tuberculous mycobacteria (NTM). By investigating phage therapy, I aims to provide alternatives to traditional antibiotics in addressing the growing issue of antimicrobial resistance in TB and NTM infections.
Key Impacts
Phage-derived endolysins as anti-microbial agents against multidrug-resistant Mycobacterium abscessus clinical isolates
Our findings demonstrate the potential of phage-derived endolysins as alternative antimicrobial agents against multidrug-resistant M. abscessus clinical isolates. Both endolysins showed in vitro bacteriolytic activity, and further research is needed to evaluate their therapeutic applicability.
Source: Conference 2024